Ampio Pharmaceuticals Inc(AMPE) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. It is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. The company's product pipeline includes Ampion, which is in phase III clinical trial, is an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado.

Current Price

$1.85

RSI

55.760

Beta:

1.8262

March 31, 2021
1.2M
-2.9M

-112.176 %
90.055 %
-352.586 %
36.489 %

$-616,000
$4,869,000
$45,175,000
$-36,218,832
$-915,141
$1,162,462
-112.651 %
-89.222 %
224.728 %
-3857.732 %
-178.724 %

$-15,894,000
$-13,630,000
$-11,183,962
$-33,291,945
$-19,163,629
$-33,714,190
-16.610 %
-21.871 %
66.406 %
-73.725 %
43.159 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.